An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06668792 · RECRUITING
Trial details
- NCT number
- NCT06668792
- Sponsor
- Biocad
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-26
- Primary completion
- 2026-02-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.